Clinical Trials
Braintumor Website

These trials were the most recently added or updated

NCT Trial Name# of CentersLast Updated

NCT02415153

  Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors
907/18/2016

NCT02311920

  Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
1007/18/2016

NCT02101905

  Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
307/18/2016

NCT02568267

  Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions)
5107/17/2016

NCT02747303

  The Clinical Relevance of Margins in Frameless Stereotactic Radiosurgery for Intact Brain Metastases: a Randomized Trial of 0 vs 2 mm Margins
107/15/2016

NCT02590263

  Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
1507/15/2016

NCT02444546

  Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Recurrent or Refractory Brain Tumors
107/15/2016

NCT02353000

  Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases
107/15/2016

NCT02511405

  A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
8907/14/2016

NCT02328300

  FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
107/14/2016

NCT02062372

  Spatial Analysis and Validation of Glioblastoma on 7 T MRI
107/14/2016

NCT01503827

  Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
2007/14/2016

NCT02834013

  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
107/13/2016

NCT02616393

  Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
707/13/2016

NCT02296580

  A Feasibility Study of the Nativis Voyager System in Patients With Recurrent Glioblastoma Multiforme (GBM)
607/13/2016

NCT02058953

  CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
107/13/2016

NCT00083512

  Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
107/13/2016

NCT02833701

  Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
107/12/2016

NCT02308020

  A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
5107/12/2016

NCT02073994

  Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
1107/12/2016

NCT01638533

  Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
607/12/2016

NCT01188096

  A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
207/12/2016

NCT01128218

  A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
107/12/2016

NCT02761070

  Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
107/11/2016

NCT02722512

  Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
107/11/2016

NCT02667587

  Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer).
4007/11/2016

NCT02617589

  Study of Nivolumab Versus Temozolomide, Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
7707/11/2016

NCT02617134

  CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
107/11/2016

NCT02576431

  Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
1807/11/2016

NCT02546102

  Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
4707/11/2016

NCT02234050

  Trabectedin for Recurrent Grade II/III Meningioma
2907/11/2016

NCT02209376

  Pilot Study of Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
107/11/2016

NCT02095132

  WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
1807/11/2016

NCT02017717

  A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
1307/11/2016

NCT01887522

  Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults
107/11/2016

NCT01843413

  Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
107/11/2016

NCT01622868

  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
6407/11/2016

NCT02358187

  A Vaccine Trial for Low Grade Gliomas
107/10/2016

NCT01130077

  A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
107/10/2016

NCT02017964

  Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma
6507/08/2016

NCT01837862

  A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
107/08/2016

NCT01592968

  A Prospective Phase III Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy
107/08/2016

NCT01473901

  A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
107/08/2016

NCT02650752

  Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
507/07/2016

NCT02575027

  Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
107/07/2016

NCT02573324

  A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
11507/07/2016

NCT01778764

  Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases
107/07/2016

NCT01770353

  Pilot Study to Determine Biodistribution of MM-398 and Feasibility of Ferumoxytol as a Tumor Imaging Agent
407/07/2016

NCT02394626

  Surgery for Recurrent Glioblastoma
407/06/2016

NCT02078648

  Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
1607/06/2016



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites